Q32 Bio (QTTB) Asset Utilization Ratio (2018 - 2024)
Q32 Bio (QTTB) recorded quarterly Asset Utilization Ratio of 0.01 in Q3 2024, down 429.49% quarter-over-quarter from 0.0 in Q2 2024, and down 120.87% on a YoY basis from 0.06 in Q4 2023.
Q32 Bio (QTTB) Asset Utilization Ratio (2018 - 2024) Analysis & Trends
Q32 Bio's Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.01 for Q3 2024.
- In Q3 2024, Asset Utilization Ratio fell 120.87% year-over-year to 0.01; the TTM figure through Sep 2024 stood at 0.01 (down 120.87% YoY), while the FY2025 annual figure was 0.7, changed N/A from the prior year.
- Asset Utilization Ratio was 0.01 for Q3 2024 at Q32 Bio, down from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.15 in Q4 2021 to a low of 0.01 in Q3 2024.
- Historically, Asset Utilization Ratio has averaged 0.05 across 5 years, with a median of 0.02 in 2022.
- The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio soared 1804.26% in 2021, then plunged 120.87% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2020, then jumped by 1298.06% to 0.15 in 2021, then slumped by 91.49% to 0.01 in 2022, then surged by 444.15% to 0.07 in 2023, then sank by 116.73% to 0.01 in 2024.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q3 2024), 0.0 (Q2 2024), and 0.04 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | 0.13 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |